These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4599577

  • 1. [Modification of cerebrovascular diseases through the oral administration of raubasine].
    Klein K, Grübl M.
    Wien Med Wochenschr; 1974 Jun 08; 124(23):360-4. PubMed ID: 4599577
    [No Abstract] [Full Text] [Related]

  • 2. [Evidence for the action of raubasine from a new formulation of Lamuran tablets].
    Glocke M, Grübl M, Klein K, Teufel W.
    Med Klin; 1976 Sep 17; 71(38):1564-8. PubMed ID: 790125
    [Abstract] [Full Text] [Related]

  • 3. [Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
    Eninia GI, Smeltere ES, Godlevska MA, Uzulinia IP.
    Klin Med (Mosk); 1982 Oct 17; 60(10):47-50. PubMed ID: 7176473
    [No Abstract] [Full Text] [Related]

  • 4. [Hemodynamic principles of therapygin cerebrovascular diseases].
    Klein K.
    Med Klin; 1973 May 04; 68(18):572-9. PubMed ID: 4576604
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M, Jacquy J, Noel G.
    Brux Med; 1974 Dec 04; 54(12):743-5. PubMed ID: 4215548
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K.
    Wien Med Wochenschr; 1973 Jan 06; 123(1):14-8. PubMed ID: 4405190
    [No Abstract] [Full Text] [Related]

  • 10. [On the demonstration of drug effects on the brain circulation].
    Klein K.
    Med Welt; 1967 Sep 02; 35():2021-5. PubMed ID: 5595992
    [No Abstract] [Full Text] [Related]

  • 11. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN, Eremeeva SV.
    Klin Med (Mosk); 1982 Oct 02; 60(10):39-42. PubMed ID: 6757560
    [No Abstract] [Full Text] [Related]

  • 12. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
    Eichhorn O.
    Vasc Dis; 1965 Nov 02; 2(6):305-15. PubMed ID: 5323511
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK, Blechacz W.
    Arzneimittelforschung; 1977 Nov 02; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract] [Full Text] [Related]

  • 15. [Cerebrovascular circulation and cephalic hypertension].
    Siedek H, Klein K.
    Wien Med Wochenschr; 1969 Feb 15; 119(7):135-7. PubMed ID: 5772003
    [No Abstract] [Full Text] [Related]

  • 16. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L, Missana M.
    Clin Ter; 1975 Sep 15; 74(5):471-84. PubMed ID: 819202
    [No Abstract] [Full Text] [Related]

  • 17. Circulatory effect of kallikrein; with special reference to cerebral circulation.
    Miyazaki M.
    Adv Exp Med Biol; 1989 Sep 15; 247B():607-10. PubMed ID: 2610098
    [No Abstract] [Full Text] [Related]

  • 18. [Use of raubasine in long-term therapy of obliterating arteriopathies].
    Andreozzi GM, Signorelli S, Magnano V, Savoca N, Mazzerbo A, Cottini E, Sorrentino F.
    Minerva Cardioangiol; 1979 Sep 15; 27(1-2):61-6. PubMed ID: 471237
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.